Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuka Hayakawa
Institutions:
Tokyo Medical and Dental University,
Musashino Red Cross Hospital
Observed institutions:
Tokyo Medical and Dental University,
Musashino Red Cross Hospital,
Institute of Science Tokyo Hospital
ORCID:
0009-0003-4344-2335
Observed ORCID:
0009-0003-4344-2335
OpenAlex ID:
A5070164078
Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice
2021
·
Yuka Hayakawa
, Kaoru Tsuchiya
, et al.
·
Investigational New Drugs
·
58
PDF
Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma
2022
·
Hiroaki Matsumoto
, Kaoru Tsuchiya
, et al.
·
Cancers
·
30
PDF
Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B
2020
·
Nobuharu Tamaki
, Masayuki Kurosaki
, et al.
·
Journal of Medical Virology
·
25
Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment
2022
·
Shun Kaneko
, Kaoru Tsuchiya
, et al.
·
JGH Open
·
18
PDF
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma
2022
·
Shun Kaneko
, Masayuki Kurosaki
, et al.
·
PLoS ONE
·
11
PDF
Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B
2022
·
Sakura Kirino
, Nobuharu Tamaki
, et al.
·
Hepatology Research
·
9
Detecting advanced liver fibrosis using ultrasound shear wave velocity measurement in the general population
2023
·
Sakura Kirino
, Nobuharu Tamaki
, et al.
·
Quantitative Imaging in Medicine and Surgery
·
6
PDF
Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy
2022
·
Yuka Hayakawa
, Nobuharu Tamaki
, et al.
·
Internal Medicine
·
6
PDF
Simple algorithm to narrow down the candidates to receive echocardiography in patients with chronic liver disease for suspected pulmonary hypertension
2022
·
Koji Yamashita
, Masayuki Kurosaki
, et al.
·
JGH Open
·
3
The therapeutic strategy for choosing lenvatinib in systemic therapy for unresectable hepatocellular carcinoma.
2022
·
Kaoru Tsuchiya
, Masayuki Kurosaki
, et al.
·
Journal of Clinical Oncology
·
2
The efficacy of molecular targeted therapies after atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma (HCC) in Japan
2022
·
Kaoru Tsuchiya
, Yuka Hayakawa
, et al.
·
Journal of Hepatology
Clinical impact of the changes of muscle volume during various systemic therapies in patients with unresectable hepatocellular carcinoma.
2022
·
Hiroaki Matsumoto
, Kaoru Tsuchiya
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
12
Citation count:
168
H-index:
6
I10-index:
5
Year
Topic
Type